Ceregene
Biotechnology company that treats neurodegenerative disorders using the delivery of nervous system growth factors.
Employees
Enterprise value
$46—69m
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
N/A | Acquisition | ||
| Total Funding | 000k | ||
Alta Partners(exited)
MPM BioImpact(exited)
California Technology Ventures(exited)
HamiltonApex Technology Ventures(exited)
Investor Growth Capital(exited)
Related Content
Analytics
Unlock the full power of analytics with a premium account
Track company size and historic growth
Track team composition and strength
Track website visits and app downloads
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.